Our comprehensive characterization of CD4+ T cells in experimental neuroinflammation and MS reveals that phase-specific markers distinguishing chronic states of neuroinflammation are detectable in the CSF of individuals with early MS. The gene discussed is CD4; the disease is myeloid sarcoma.